Market Overview:
The global controlled-release drug delivery technology market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for advanced drug delivery technologies, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global controlled-release drug delivery technology market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery and others. The wurster technique segment is expected to account for the largest share of the global controlled-release drug delivery technology market in 2018. This segment is also projected to grow at a high CAGR during the forecast period from 2018 to 2030. This growth can be attributed to its ability to provide improved solubility and bioavailability of drugs as well as better patient compliance rates compared with other types of controlled-release drug delivery technologies. Based on application, the global Controlled Drug Delivery Technology Market is divided into metered dose inhalers (MDIs), injectables (including large molecules such as monoclonal antibodies (mAbs)), transdermal and ocular patches Infusion pumps Oral Controlled Drug Delivery Systems Drug eluting stents Others).
Product Definition:
Drug delivery technology that controls the rate at which a drug is released from a dosage form. Controlled-release drug delivery technology is important because it can improve the effectiveness of drugs while reducing their side effects.
Wurster Technique:
Wurster technique is a method of preparing highly porous ceramics or polymeric matrix materials, which can be used for controlled release of drugs. This method was developed by the German Nobel laureate Walther Wurster in the early 1960s. The basic concept behind this technique is to create micro-porous and macroscopic pore structure on the surface of solid material by using an appropriate surfactant/polymer mixture along with water as a carrier medium.
Coacervation:
Coacervation is a method of preserving biological materials such as enzymes, proteins, and nucleic acids. Coacervation involves the formation of an oil-in-water emulsion which is stable at room temperature. The process allows for the controlled release of these materials from the emulsion during administration by maintaining stability throughout drug development and clinical use.
Application Insights:
Metered dose inhalers (MDIs) application dominated the global controlled-release drug delivery technology market in terms of revenue share in 2017. MDIs are used for the treatment of asthma and other lung diseases such as cystic fibrosis, bronchiectasis, and pulmonary hypertension. The high usage rate of metered dose inhalers is primarily due to its ease of use along with a low failure rate associated with it. Moreover, increasing R&D activities pertaining to the development of novel metering devices that can deliver drugs in a precise dosage is expected to drive growth over the forecast period.
Injectables were estimated as one of the fastest growing segments owing to factors such as increasing number procedures being performed using injectable drugs coupled with an increase in research & development activities pertaining to new drug delivery systems using various types Controlled-Release Drug Delivery Technology (CRDT).
Regional Analysis:
North America dominated the global market in 2017. The dominance of this region is majorly attributed to factors such as local presence of key players, high disposable income, and technological advancements. Moreover, increasing FDA approvals for C-R technology coupled with rising product launches are also expected to drive the regional market over the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases: The global controlled-release drug delivery technology market is expected to grow at a CAGR of 9.5% during the forecast period, owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.
- Technological advancements: The controlled-release drug delivery technology market is witnessing technological advancements in terms of product design and development that are helping in improving patient compliance and reducing side effects associated with drugs. This is driving the growth of this market.
- Rising demand for targeted drug delivery: The growing demand for targeted drug delivery systems is another major factor propelling the growth of the global controlled-release drug delivery technology market . This system helps in delivering drugs directly to the site where they are required, which reduces systemic exposure and adverse effects associated with traditional therapies..
- thereby creating a large pool of patients susceptible to various chronic diseases that can be treated using controlled-release formulations.. 5) Increasing investments by pharmaceutical companies: Pharmaceutical companies are increasingly investing in research and development activities for new products that use advanced technologies such ascontrolled releasein order to improve patient compliance ratesand reduce side effects
Scope Of The Report
Report Attributes
Report Details
Report Title
Controlled-Release Drug Delivery Technology Market Research Report
By Type
Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others
By Application
Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents, Others
By Companies
Depomed, Coating Place, Corium International, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel, Merck and Co, Aradigm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Controlled-Release Drug Delivery Technology Market Report Segments:
The global Controlled-Release Drug Delivery Technology market is segmented on the basis of:
Types
Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Depomed
- Coating Place
- Corium International
- Johnson and Johnson
- Alkermes
- Pfizer
- Orbis Biosciences
- Capsugel
- Merck and Co
- Aradigm
Highlights of The Controlled-Release Drug Delivery Technology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
- By Application:
- Metered Dose Inhalers
- Injectables
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
- Drug Eluting Stents
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Controlled-Release Drug Delivery Technology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Controlled-release drug delivery technology is a method of delivering drugs to the body that allows for controlled and sustained release of the drug over an extended period of time. Controlled-release technologies allow for lower doses to be administered over a longer period of time, which can reduce the potential side effects associated with taking medications.
Some of the major companies in the controlled-release drug delivery technology market are Depomed, Coating Place, Corium International, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel, Merck and Co, Aradigm.
The controlled-release drug delivery technology market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Controlled-Release Drug Delivery Technology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Controlled-Release Drug Delivery Technology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Controlled-Release Drug Delivery Technology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Controlled-Release Drug Delivery Technology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Controlled-Release Drug Delivery Technology Market Size & Forecast, 2018-2028
4.5.1 Controlled-Release Drug Delivery Technology Market Size and Y-o-Y Growth
4.5.2 Controlled-Release Drug Delivery Technology Market Absolute $ Opportunity
Chapter 5 Global Controlled-Release Drug Delivery Technology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Controlled-Release Drug Delivery Technology Market Size Forecast by Type
5.2.1 Wurster Technique
5.2.2 Coacervation
5.2.3 Micro Encapsulation
5.2.4 Implants
5.2.5 Transdermal
5.2.6 Targeted Delivery
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Controlled-Release Drug Delivery Technology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
6.2.1 Metered Dose Inhalers
6.2.2 Injectables
6.2.3 Transdermal and Ocular Patches
6.2.4 Infusion Pumps
6.2.5 Oral Controlled-Drug Delivery Systems
6.2.6 Drug Eluting Stents
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Controlled-Release Drug Delivery Technology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Controlled-Release Drug Delivery Technology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Controlled-Release Drug Delivery Technology Analysis and Forecast
9.1 Introduction
9.2 North America Controlled-Release Drug Delivery Technology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Controlled-Release Drug Delivery Technology Market Size Forecast by Type
9.6.1 Wurster Technique
9.6.2 Coacervation
9.6.3 Micro Encapsulation
9.6.4 Implants
9.6.5 Transdermal
9.6.6 Targeted Delivery
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
9.10.1 Metered Dose Inhalers
9.10.2 Injectables
9.10.3 Transdermal and Ocular Patches
9.10.4 Infusion Pumps
9.10.5 Oral Controlled-Drug Delivery Systems
9.10.6 Drug Eluting Stents
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Controlled-Release Drug Delivery Technology Analysis and Forecast
10.1 Introduction
10.2 Europe Controlled-Release Drug Delivery Technology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Controlled-Release Drug Delivery Technology Market Size Forecast by Type
10.6.1 Wurster Technique
10.6.2 Coacervation
10.6.3 Micro Encapsulation
10.6.4 Implants
10.6.5 Transdermal
10.6.6 Targeted Delivery
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
10.10.1 Metered Dose Inhalers
10.10.2 Injectables
10.10.3 Transdermal and Ocular Patches
10.10.4 Infusion Pumps
10.10.5 Oral Controlled-Drug Delivery Systems
10.10.6 Drug Eluting Stents
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Controlled-Release Drug Delivery Technology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Controlled-Release Drug Delivery Technology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Controlled-Release Drug Delivery Technology Market Size Forecast by Type
11.6.1 Wurster Technique
11.6.2 Coacervation
11.6.3 Micro Encapsulation
11.6.4 Implants
11.6.5 Transdermal
11.6.6 Targeted Delivery
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
11.10.1 Metered Dose Inhalers
11.10.2 Injectables
11.10.3 Transdermal and Ocular Patches
11.10.4 Infusion Pumps
11.10.5 Oral Controlled-Drug Delivery Systems
11.10.6 Drug Eluting Stents
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Controlled-Release Drug Delivery Technology Analysis and Forecast
12.1 Introduction
12.2 Latin America Controlled-Release Drug Delivery Technology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Controlled-Release Drug Delivery Technology Market Size Forecast by Type
12.6.1 Wurster Technique
12.6.2 Coacervation
12.6.3 Micro Encapsulation
12.6.4 Implants
12.6.5 Transdermal
12.6.6 Targeted Delivery
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
12.10.1 Metered Dose Inhalers
12.10.2 Injectables
12.10.3 Transdermal and Ocular Patches
12.10.4 Infusion Pumps
12.10.5 Oral Controlled-Drug Delivery Systems
12.10.6 Drug Eluting Stents
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Controlled-Release Drug Delivery Technology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Controlled-Release Drug Delivery Technology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Controlled-Release Drug Delivery Technology Market Size Forecast by Type
13.6.1 Wurster Technique
13.6.2 Coacervation
13.6.3 Micro Encapsulation
13.6.4 Implants
13.6.5 Transdermal
13.6.6 Targeted Delivery
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Controlled-Release Drug Delivery Technology Market Size Forecast by Applications
13.10.1 Metered Dose Inhalers
13.10.2 Injectables
13.10.3 Transdermal and Ocular Patches
13.10.4 Infusion Pumps
13.10.5 Oral Controlled-Drug Delivery Systems
13.10.6 Drug Eluting Stents
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Controlled-Release Drug Delivery Technology Market: Competitive Dashboard
14.2 Global Controlled-Release Drug Delivery Technology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Depomed
14.3.2 Coating Place
14.3.3 Corium International
14.3.4 Johnson and Johnson
14.3.5 Alkermes
14.3.6 Pfizer
14.3.7 Orbis Biosciences
14.3.8 Capsugel
14.3.9 Merck and Co
14.3.10 Aradigm
